| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.02e-04 | 42 | 116 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 1.30e-04 | 84 | 116 | 5 | GO:0003684 | |
| GeneOntologyMolecularFunction | tubulin binding | CLIP1 KIF20B CDK5R1 BRCA1 KIF15 CEP135 MACF1 ARHGEF2 CEP57 VBP1 | 1.99e-04 | 428 | 116 | 10 | GO:0015631 |
| GeneOntologyMolecularFunction | cytoskeletal regulatory protein binding | 3.31e-04 | 5 | 116 | 2 | GO:0005519 | |
| GeneOntologyCellularComponent | postsynaptic density | ERC1 ADAM10 CDK5R1 LRRTM4 LRRTM2 ANP32E MACF1 ARHGEF2 HOMER2 SNX1 | 1.96e-04 | 451 | 115 | 10 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | ERC1 ADAM10 CDK5R1 LRRTM4 LRRTM2 ANP32E MACF1 ARHGEF2 HOMER2 SNX1 | 3.06e-04 | 477 | 115 | 10 | GO:0032279 |
| GeneOntologyCellularComponent | cell leading edge | TRPV1 RIPOR2 IQGAP2 ACTN1 CLIP1 AMOTL1 MACF1 PKN2 ARHGEF2 SNX1 | 4.44e-04 | 500 | 115 | 10 | GO:0031252 |
| GeneOntologyCellularComponent | postsynaptic specialization | ERC1 ADAM10 CDK5R1 LRRTM4 LRRTM2 ANP32E MACF1 ARHGEF2 HOMER2 SNX1 | 4.65e-04 | 503 | 115 | 10 | GO:0099572 |
| GeneOntologyCellularComponent | nuclear chromosome | 5.18e-04 | 254 | 115 | 7 | GO:0000228 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 5.34e-04 | 29 | 115 | 3 | GO:0097038 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | ERC1 ADAM10 CDK5R1 LRRTM4 LRRTM2 ANP32E MACF1 ARHGEF2 HOMER2 SNX1 | 6.29e-04 | 523 | 115 | 10 | GO:0098984 |
| GeneOntologyCellularComponent | male pronucleus | 8.22e-04 | 8 | 115 | 2 | GO:0001940 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 1.25e-03 | 85 | 115 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | female pronucleus | 1.31e-03 | 10 | 115 | 2 | GO:0001939 | |
| GeneOntologyCellularComponent | postsynapse | TRPV1 CTTNBP2 ERC1 ACTN1 ADAM10 RNF220 CDK5R1 LRRTM4 LRRTM2 ANP32E MACF1 ARHGEF2 HOMER2 SNX1 | 1.41e-03 | 1018 | 115 | 14 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic endosome membrane | 1.60e-03 | 11 | 115 | 2 | GO:0098895 | |
| GeneOntologyCellularComponent | microtubule organizing center | ERC1 SFR1 BBS9 CLIP1 KIF20B BRCA1 KIF15 CEP89 USO1 CEP135 PKN2 CEP57 DEUP1 | 1.63e-03 | 919 | 115 | 13 | GO:0005815 |
| Domain | Leu-rich_rpt | LRRC57 AMN1 TLR7 LRRC47 NOD2 PPP1R7 LRIG3 LRRC31 SLIT1 LRRTM4 LRRTM2 ANP32E LRRC36 | 1.00e-08 | 271 | 113 | 13 | IPR001611 |
| Domain | LRR | LRRC57 TLR7 LRRC47 NOD2 PPP1R7 LRIG3 SLIT1 LRRTM4 LRRTM2 ANP32E LRRC36 | 3.81e-08 | 201 | 113 | 11 | PS51450 |
| Domain | - | LRRC57 AMN1 TLR7 LRRC47 NOD2 PPP1R7 LRIG3 LRRC31 SLIT1 LRRTM4 LRRTM2 ANP32E LRRC36 | 7.37e-08 | 321 | 113 | 13 | 3.80.10.10 |
| Domain | LRR_1 | LRRC57 TLR7 LRRC47 PPP1R7 LRIG3 LRRC31 SLIT1 LRRTM4 LRRTM2 ANP32E LRRC36 | 9.15e-08 | 219 | 113 | 11 | PF00560 |
| Domain | L_dom-like | LRRC57 AMN1 TLR7 LRRC47 NOD2 PPP1R7 LRIG3 LRRC31 SLIT1 LRRTM4 LRRTM2 ANP32E LRRC36 | 9.46e-08 | 328 | 113 | 13 | IPR032675 |
| Domain | Leu-rich_rpt_typical-subtyp | 1.22e-05 | 177 | 113 | 8 | IPR003591 | |
| Domain | LRR_TYP | 1.22e-05 | 177 | 113 | 8 | SM00369 | |
| Domain | Prefoldin | 7.51e-05 | 72 | 113 | 5 | IPR009053 | |
| Domain | LRR_8 | 8.16e-05 | 171 | 113 | 7 | PF13855 | |
| Domain | LAMININ_IVB | 1.08e-04 | 3 | 113 | 2 | PS51116 | |
| Domain | Laminin_IV_B | 1.08e-04 | 3 | 113 | 2 | IPR013015 | |
| Domain | LRRNT | 3.22e-04 | 98 | 113 | 5 | IPR000372 | |
| Domain | LRRNT | 3.22e-04 | 98 | 113 | 5 | SM00013 | |
| Domain | LRRCT | 9.41e-04 | 32 | 113 | 3 | PF01463 | |
| Domain | ARM_REPEAT | 1.81e-03 | 40 | 113 | 3 | PS50176 | |
| Domain | LRRcap | 1.93e-03 | 11 | 113 | 2 | SM00446 | |
| Domain | U2A'_phosphoprotein32A_C | 1.93e-03 | 11 | 113 | 2 | IPR003603 | |
| Domain | Ank_2 | 1.97e-03 | 215 | 113 | 6 | PF12796 | |
| Domain | Oxysterol-bd | 2.30e-03 | 12 | 113 | 2 | IPR000648 | |
| Domain | Oxysterol-bd_CS | 2.30e-03 | 12 | 113 | 2 | IPR018494 | |
| Domain | Oxysterol_BP | 2.30e-03 | 12 | 113 | 2 | PF01237 | |
| Domain | OSBP | 2.30e-03 | 12 | 113 | 2 | PS01013 | |
| Domain | Ank | 2.65e-03 | 228 | 113 | 6 | PF00023 | |
| Domain | PH | 2.70e-03 | 229 | 113 | 6 | PF00169 | |
| Domain | Diacylglycerol_kinase_cat_dom | 3.62e-03 | 15 | 113 | 2 | IPR001206 | |
| Domain | DAGK_cat | 3.62e-03 | 15 | 113 | 2 | PF00781 | |
| Domain | DAGK | 3.62e-03 | 15 | 113 | 2 | PS50146 | |
| Domain | - | 4.00e-03 | 248 | 113 | 6 | 1.25.40.20 | |
| Domain | Laminin_N | 4.12e-03 | 16 | 113 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 4.12e-03 | 16 | 113 | 2 | PS51117 | |
| Domain | Laminin_N | 4.12e-03 | 16 | 113 | 2 | PF00055 | |
| Domain | Actin_CS | 4.12e-03 | 16 | 113 | 2 | IPR004001 | |
| Domain | LamNT | 4.12e-03 | 16 | 113 | 2 | SM00136 | |
| Domain | ANK | 4.24e-03 | 251 | 113 | 6 | SM00248 | |
| Domain | ANK_REPEAT | 4.40e-03 | 253 | 113 | 6 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 4.49e-03 | 254 | 113 | 6 | IPR020683 | |
| Domain | ANK_REP_REGION | 4.49e-03 | 254 | 113 | 6 | PS50297 | |
| Domain | LRR_6 | 4.50e-03 | 55 | 113 | 3 | PF13516 | |
| Domain | ARM-type_fold | 4.56e-03 | 339 | 113 | 7 | IPR016024 | |
| Domain | ACTINS_2 | 4.65e-03 | 17 | 113 | 2 | PS00432 | |
| Domain | NAD/diacylglycerol_kinase | 4.65e-03 | 17 | 113 | 2 | IPR016064 | |
| Domain | Actin/actin-like_CS | 5.21e-03 | 18 | 113 | 2 | IPR020902 | |
| Domain | Ankyrin_rpt | 5.21e-03 | 262 | 113 | 6 | IPR002110 | |
| Domain | BRCT | 5.80e-03 | 19 | 113 | 2 | PF00533 | |
| Domain | ACTINS_ACT_LIKE | 5.80e-03 | 19 | 113 | 2 | PS01132 | |
| Pathway | REACTOME_DEUBIQUITINATION | 7.04e-05 | 299 | 84 | 9 | M27574 | |
| Pathway | REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES | 8.23e-05 | 39 | 84 | 4 | M27579 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DOCK4 NRIP1 HDAC5 ERC1 TNIP1 TRIP11 KIF20B ARFGEF3 POTEE KIF15 USO1 N4BP2 ANP32E MACF1 POTEI GOLGB1 | 1.52e-10 | 588 | 117 | 16 | 38580884 |
| Pubmed | DOCK4 RIPOR2 HDAC5 ERC1 ARFGEF3 LRIG3 SLIT1 LRRTM2 MACF1 ANKRD12 TET3 XPO7 | 1.42e-08 | 407 | 117 | 12 | 12693553 | |
| Pubmed | CTTNBP2 IQGAP2 ERC1 ARHGEF18 CLIP1 TRIP11 GATAD2B PPP1R7 PARP1 KIF15 OSBPL3 N4BP2 CCAR1 MACF1 ARHGEF2 HOMER2 GOLGB1 | 2.57e-08 | 963 | 117 | 17 | 28671696 | |
| Pubmed | IQGAP2 TRIP11 ARFGEF3 LRIG3 RIF1 BRCA1 USO1 DDX18 AMOTL1 DCLRE1A FKBP8 SNX1 GOLGB1 AGAP1 XPO7 | 5.77e-08 | 777 | 117 | 15 | 35844135 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPM4 ATAD5 CDK12 ERC1 SMCHD1 TRIP11 PARP1 RIF1 ANP32E MACF1 PKN2 SNX1 VBP1 GOLGB1 RBM17 | 6.03e-07 | 934 | 117 | 15 | 33916271 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ATAD5 SMCHD1 POLH KIF20B GATAD2B FSIP2 RNF220 PARP1 RIF1 BRCA1 USP3 ZNF292 | 1.06e-06 | 608 | 117 | 12 | 36089195 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | LAMB4 CTTNBP2 USP25 LRRC47 BLMH USP26 RNF220 PARP1 BRCA1 AMOTL1 PKN2 FKBP8 ARHGEF2 USP3 VBP1 | 1.50e-06 | 1005 | 117 | 15 | 19615732 |
| Pubmed | 1.61e-06 | 418 | 117 | 10 | 34709266 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | TICRR ATAD5 SMCHD1 SREBF1 G2E3 GATAD2B PARP1 RIF1 BRCA1 OSBPL3 DDX18 CCAR1 DCLRE1A USP3 ANAPC5 TET3 RBM17 | 1.61e-06 | 1294 | 117 | 17 | 30804502 |
| Pubmed | ERC1 SMCHD1 SREBF1 LAMB1 CLIP1 TRIP11 PARP1 DDX18 FKBP8 YME1L1 SNX1 GOLGB1 RBM17 | 1.65e-06 | 754 | 117 | 13 | 35906200 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPM4 USP25 LAMB1 ACTN1 CLIP1 AARSD1 LRRC47 BLMH PPP1R7 GRPEL1 SARS1 KIF15 ANP32E MACF1 POLD3 SNX1 VBP1 XPO7 | 1.81e-06 | 1455 | 117 | 18 | 22863883 |
| Pubmed | ATAD5 SMCHD1 LAMB1 GATAD2B BLMH POTEE PARP1 RIF1 BRCA1 DDX18 CCAR1 DCLRE1A | 2.18e-06 | 652 | 117 | 12 | 31180492 | |
| Pubmed | 2.28e-06 | 251 | 117 | 8 | 29778605 | ||
| Pubmed | 2.72e-06 | 257 | 117 | 8 | 30945288 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | SMCHD1 LDAF1 TNIP1 ACVR2A CLIP1 LRRC47 LRIG3 RIF1 USO1 MACF1 FKBP8 POLD3 ARHGEF2 SNX1 GOLGB1 | 2.90e-06 | 1061 | 117 | 15 | 33845483 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CPA4 SMCHD1 ACTN1 KIF20B AARSD1 LRRC47 BLMH PARP1 RIF1 DDX18 CCAR1 MACF1 PKN2 POLD3 ARHGEF2 USP3 YME1L1 | 2.94e-06 | 1353 | 117 | 17 | 29467282 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | TPM4 KRT78 ACTN1 AARSD1 LRRC47 BLMH PARP1 GRPEL1 USO1 DDX18 CCAR1 ANP32E SNX1 VBP1 GOLGB1 RBM17 XPO7 | 3.37e-06 | 1367 | 117 | 17 | 32687490 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CDK12 SMCHD1 LRRC47 PARP1 RIF1 USO1 MACF1 PKN2 ARHGEF2 GOLGB1 RBM17 | 4.60e-06 | 582 | 117 | 11 | 20467437 |
| Pubmed | 5.17e-06 | 129 | 117 | 6 | 23022380 | ||
| Pubmed | USP25 TNIP1 ACTN1 RNF220 BRCA1 KIF15 ANP32E MACF1 ARHGEF2 USP3 | 5.56e-06 | 481 | 117 | 10 | 28190767 | |
| Pubmed | Characterization and Genetic Analyses of New Genes Coding for NOD2 Interacting Proteins. | 5.88e-06 | 35 | 117 | 4 | 27812135 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 6.00e-06 | 203 | 117 | 7 | 22083510 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | KRT78 ATAD5 ERC1 SARS1 BRCA1 DDX18 CCAR1 MACF1 DCLRE1A PKN2 ZNF292 RBM17 | 6.32e-06 | 724 | 117 | 12 | 36232890 |
| Pubmed | NRIP1 ERC1 USP25 LAMB1 ACTN1 TRIP11 RNF220 PARP1 DDX18 KCNN1 CCAR1 MACF1 YME1L1 SNX1 AGAP1 ZNF292 | 6.63e-06 | 1285 | 117 | 16 | 35914814 | |
| Pubmed | TPM4 IQGAP2 ERC1 SMCHD1 ACTN1 POTEE PARP1 GRPEL1 BRCA1 N4BP2 CCAR1 MACF1 POTEI ARHGEF2 CEP57 GOLGB1 ZNF292 | 6.82e-06 | 1442 | 117 | 17 | 35575683 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 KRT78 ERC1 TRIP11 ARFGEF3 FSIP2 CEP89 USO1 OSBPL3 N4BP2 MACF1 ARHGEF2 GOLGB1 | 6.95e-06 | 861 | 117 | 13 | 36931259 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPM4 IQGAP2 CDK12 ERC1 ACTN1 BLMH PPP1R7 PARP1 SARS1 USO1 AMOTL1 ANP32E MACF1 POLD3 VBP1 | 7.55e-06 | 1149 | 117 | 15 | 35446349 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | HDAC5 IQGAP2 ERC1 ACTN1 BBS9 CLIP1 TRIP11 LRRC47 PPP1R7 TBC1D32 RIF1 NPHP3 OSBPL3 AMOTL1 YME1L1 AGAP1 | 9.35e-06 | 1321 | 117 | 16 | 27173435 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | TICRR IQGAP2 ATAD5 CDK12 SMCHD1 KIF20B RIF1 DDX18 MACF1 ARHGEF2 YME1L1 RBM17 | 1.01e-05 | 759 | 117 | 12 | 35915203 |
| Pubmed | ATAD5 LAMB1 TNIP1 LRRC47 PARP1 GRPEL1 SARS1 CEP89 N4BP2 DDX18 ANP32E MACF1 PKN2 FKBP8 YME1L1 SNX1 GOLGB1 | 1.02e-05 | 1487 | 117 | 17 | 33957083 | |
| Pubmed | 1.11e-05 | 86 | 117 | 5 | 37253089 | ||
| Pubmed | ATAD5 CDK12 ACTN1 KIF20B GATAD2B POTEE RIF1 BRCA1 ZNF277 CCAR1 MACF1 FKBP8 ARHGEF2 ANAPC5 YME1L1 GOLGB1 AGAP1 | 1.11e-05 | 1497 | 117 | 17 | 31527615 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 25981734 | ||
| Pubmed | RIF1 counteracts BRCA1-mediated end resection during DNA repair. | 1.12e-05 | 2 | 117 | 2 | 23486525 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 21607289 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 21187397 | ||
| Pubmed | Finer delineation and transcript map of the 7q31 locus deleted in myeloid neoplasms. | 1.12e-05 | 2 | 117 | 2 | 16213364 | |
| Pubmed | Effect of adriamycin on BRCA1 and PARP-1 expression in MCF-7 breast cancer cells. | 1.12e-05 | 2 | 117 | 2 | 25337234 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 27362900 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 30786684 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 33352773 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 22392482 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 27742776 | ||
| Pubmed | ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance. | 1.12e-05 | 2 | 117 | 2 | 37823600 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 30231795 | ||
| Pubmed | ATAD5 ERC1 BLMH PPP1R7 PARP1 RIF1 GRPEL1 KIF15 CEP89 CEP135 FKBP8 ARHGEF2 YME1L1 VBP1 | 1.22e-05 | 1049 | 117 | 14 | 27880917 | |
| Pubmed | 1.74e-05 | 549 | 117 | 10 | 38280479 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ATAD5 CDK12 SMCHD1 POLH KIF20B GATAD2B PARP1 RIF1 BRCA1 DDX18 SIMC1 CCAR1 RBM17 | 2.05e-05 | 954 | 117 | 13 | 36373674 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPM4 ERC1 SMCHD1 ACTN1 LRRC47 PARP1 RIF1 SARS1 USO1 DDX18 ANP32E MACF1 PKN2 ARHGEF2 SNX1 GOLGB1 | 2.17e-05 | 1415 | 117 | 16 | 28515276 |
| Pubmed | 2.44e-05 | 17 | 117 | 3 | 29299163 | ||
| Pubmed | 2.54e-05 | 102 | 117 | 5 | 9734811 | ||
| Pubmed | The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair. | 3.06e-05 | 106 | 117 | 5 | 31024071 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 27878232 | ||
| Pubmed | ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling. | 3.36e-05 | 3 | 117 | 2 | 19464428 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 12592385 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 25483710 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 17318223 | ||
| Pubmed | RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer. | 3.36e-05 | 3 | 117 | 2 | 28034904 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 25865228 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 31916449 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 31329989 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 29025359 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 24191908 | ||
| Pubmed | NOD2 and CCDC122-LACC1 genes are associated with leprosy susceptibility in Brazilians. | 3.36e-05 | 3 | 117 | 2 | 25367361 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 22565312 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 33036707 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 25103497 | ||
| Pubmed | Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations. | 3.36e-05 | 3 | 117 | 2 | 21487248 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 22093807 | ||
| Pubmed | The p115-interactive proteins GM130 and giantin participate in endoplasmic reticulum-Golgi traffic. | 3.36e-05 | 3 | 117 | 2 | 11035033 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 22586318 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 24378347 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 27550455 | ||
| Pubmed | ATAD5 CDK12 SMCHD1 GATAD2B PARP1 RIF1 DDX18 CCAR1 ANP32E POLD3 VBP1 RBM17 XPO7 | 3.85e-05 | 1014 | 117 | 13 | 32416067 | |
| Pubmed | 4.06e-05 | 20 | 117 | 3 | 32079660 | ||
| Pubmed | 4.11e-05 | 486 | 117 | 9 | 20936779 | ||
| Pubmed | NRIP1 SREBF1 LAMB1 TNIP1 ACTN1 TRIP11 RNF220 BRCA1 ZNF277 SLIT1 | 4.14e-05 | 608 | 117 | 10 | 16713569 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TPM4 ARMC10 DGKH TRIP11 ARFGEF3 POTEE PARP1 GRPEL1 SARS1 OSBPL3 DDX18 FKBP8 ARHGEF2 YME1L1 VBP1 GOLGB1 | 4.24e-05 | 1496 | 117 | 16 | 32877691 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | KRT78 SMCHD1 ACTN1 BLMH PARP1 RIF1 DDX18 MACF1 FKBP8 ARHGEF2 GOLGB1 RBM17 XPO7 | 4.25e-05 | 1024 | 117 | 13 | 24711643 |
| Pubmed | CTTNBP2 ARHGEF18 TNIP1 GATAD2B NPHP3 OSBPL3 N4BP2 CEP135 MACF1 | 4.59e-05 | 493 | 117 | 9 | 15368895 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 4.85e-05 | 281 | 117 | 7 | 28706196 | |
| Pubmed | Neddylation modification of the U3 snoRNA-binding protein RRP9 by Smurf1 promotes tumorigenesis. | 4.91e-05 | 117 | 117 | 5 | 34662580 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 5.79e-05 | 289 | 117 | 7 | 23752268 | |
| Pubmed | TPM4 IQGAP2 CDK12 SMCHD1 CLIP1 LRRC47 PARP1 RIF1 GRPEL1 USO1 OSBPL3 DDX18 CCAR1 ARHGEF2 RBM17 | 5.82e-05 | 1371 | 117 | 15 | 36244648 | |
| Pubmed | Interactomic analysis reveals a homeostatic role for the HIV restriction factor TRIM5α in mitophagy. | 6.17e-05 | 292 | 117 | 7 | 35545034 | |
| Pubmed | 6.18e-05 | 638 | 117 | 10 | 33239621 | ||
| Pubmed | Inhibition of Aurora-B kinase activity by poly(ADP-ribosyl)ation in response to DNA damage. | 6.70e-05 | 4 | 117 | 2 | 16179389 | |
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 31875558 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 15650754 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 33030583 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 27494840 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 10931861 | ||
| Pubmed | Visualization of trigeminal ganglion sensory neuronal signaling regulated by Cdk5. | 6.70e-05 | 4 | 117 | 2 | 35263573 | |
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 26916217 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 15718469 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 20173781 | ||
| Pubmed | De novo DNA methylation drives 5hmC accumulation in mouse zygotes. | 6.70e-05 | 4 | 117 | 2 | 26751286 | |
| Pubmed | Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer. | 6.70e-05 | 4 | 117 | 2 | 22504414 | |
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 16860615 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 21553025 | ||
| Interaction | FBXO42 interactions | DOCK4 ERC1 TNIP1 TRIP11 KIF20B ARFGEF3 POTEE PARP1 KIF15 USO1 MACF1 GOLGB1 | 3.32e-08 | 259 | 116 | 12 | int:FBXO42 |
| Interaction | H3C1 interactions | HDAC5 ATAD5 SMCHD1 TNIP1 KIF20B GATAD2B ANKRD18B PARP1 RIF1 GRPEL1 SARS1 DDX18 ANP32E POLD3 USP3 ANAPC5 ZNF292 | 1.56e-05 | 901 | 116 | 17 | int:H3C1 |
| Interaction | HDAC1 interactions | NRIP1 HDAC5 ERC1 POLH SREBF1 TNIP1 KIF20B GATAD2B TBC1D32 PARP1 CDK5R1 BRCA1 KIF15 USO1 CEP135 POLD3 VBP1 GOLGB1 DNMT3L | 1.79e-05 | 1108 | 116 | 19 | int:HDAC1 |
| Interaction | SEPTIN10 interactions | 2.00e-05 | 144 | 116 | 7 | int:SEPTIN10 | |
| Interaction | PFN1 interactions | DOCK4 HDAC5 ERC1 TNIP1 ADAM10 TRIP11 PARP1 BRCA1 KIF15 N4BP2 MACF1 GOLGB1 | 3.77e-05 | 509 | 116 | 12 | int:PFN1 |
| Interaction | HECTD1 interactions | NRIP1 TICRR IQGAP2 ATAD5 CDK12 SMCHD1 SREBF1 KIF20B AARSD1 PARP1 RIF1 LRRC31 DDX18 MACF1 ARHGEF2 YME1L1 RBM17 | 4.74e-05 | 984 | 116 | 17 | int:HECTD1 |
| Interaction | REV1 interactions | 4.75e-05 | 35 | 116 | 4 | int:REV1 | |
| Interaction | ITPRID2 interactions | 6.84e-05 | 120 | 116 | 6 | int:ITPRID2 | |
| Interaction | VCL interactions | 6.85e-05 | 305 | 116 | 9 | int:VCL | |
| Interaction | CEBPB interactions | TPM4 TICRR KRT78 ERC1 SMCHD1 CLIP1 KIF20B GATAD2B BLMH PARP1 GRPEL1 BRCA1 USO1 DDX18 CCAR1 ANP32E FKBP8 POLD3 SNX1 VBP1 ZNF292 | 6.95e-05 | 1443 | 116 | 21 | int:CEBPB |
| Interaction | BICD1 interactions | 1.01e-04 | 250 | 116 | 8 | int:BICD1 | |
| Interaction | CEP43 interactions | 1.16e-04 | 190 | 116 | 7 | int:CEP43 | |
| Interaction | LRRC61 interactions | 1.18e-04 | 44 | 116 | 4 | int:LRRC61 | |
| Interaction | H2BC8 interactions | ATAD5 SMCHD1 KIF20B GATAD2B POTEE PARP1 RIF1 BRCA1 ANP32E POLD3 USP3 ZNF292 | 1.22e-04 | 576 | 116 | 12 | int:H2BC8 |
| Interaction | KDM4D interactions | 1.29e-04 | 45 | 116 | 4 | int:KDM4D | |
| Interaction | PXN interactions | 1.36e-04 | 334 | 116 | 9 | int:PXN | |
| Interaction | SHANK3 interactions | CTTNBP2 ACTN1 ADAM10 ARFGEF3 PPP1R7 KIF15 USO1 MACF1 FKBP8 HOMER2 RBM17 | 1.38e-04 | 496 | 116 | 11 | int:SHANK3 |
| Interaction | NID2 interactions | 1.39e-04 | 86 | 116 | 5 | int:NID2 | |
| Interaction | DCTN1 interactions | TRPV1 TNIP1 ADAM10 CLIP1 NOD2 BRCA1 USO1 CCAR1 MACF1 ARHGEF2 SNX1 | 1.40e-04 | 497 | 116 | 11 | int:DCTN1 |
| Interaction | FXR1 interactions | HDAC5 TNIP1 ACTN1 ADAM10 CLIP1 CEP89 N4BP2 SLIT1 KCNN1 CCAR1 ARHGEF2 HOMER2 GOLGB1 | 1.46e-04 | 679 | 116 | 13 | int:FXR1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q31 | 3.13e-05 | 140 | 117 | 5 | chr7q31 | |
| Cytoband | 17q21 | 5.73e-04 | 63 | 117 | 3 | 17q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q21 | 5.73e-04 | 63 | 117 | 3 | chr11q21 | |
| Cytoband | 10q25.1 | 8.54e-04 | 17 | 117 | 2 | 10q25.1 | |
| Cytoband | 7q31.1 | 1.31e-03 | 21 | 117 | 2 | 7q31.1 | |
| Cytoband | 10p14 | 2.01e-03 | 26 | 117 | 2 | 10p14 | |
| Cytoband | 7q31 | 2.17e-03 | 27 | 117 | 2 | 7q31 | |
| Cytoband | 17q11.2 | 2.86e-03 | 110 | 117 | 3 | 17q11.2 | |
| Cytoband | 21q11.2 | 3.04e-03 | 32 | 117 | 2 | 21q11.2 | |
| GeneFamily | Ankyrin repeat domain containing | 3.42e-05 | 242 | 68 | 7 | 403 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.24e-04 | 206 | 68 | 6 | 682 | |
| GeneFamily | Laminin subunits | 8.98e-04 | 12 | 68 | 2 | 626 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 8.98e-04 | 12 | 68 | 2 | 670 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.06e-03 | 13 | 68 | 2 | 685 | |
| GeneFamily | Ubiquitin specific peptidases | 1.22e-03 | 56 | 68 | 3 | 366 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.81e-03 | 181 | 68 | 4 | 694 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | NRIP1 CTTNBP2 IQGAP2 SMCHD1 USP25 CLIP1 TRIP11 KIF20B RIF1 BRCA1 KIF15 CCAR1 CEP57 GOLGB1 RBM17 | 1.92e-07 | 656 | 115 | 15 | M18979 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | TICRR ATAD5 G2E3 KIF20B BLMH PPP1R7 PARP1 RIF1 GRPEL1 BRCA1 KIF15 OSBPL3 N4BP2 DDX18 CEP135 ANP32E POLD3 YME1L1 AGAP1 XPO7 | 8.03e-07 | 1290 | 115 | 20 | M80 |
| Coexpression | GSE14415_INDUCED_VS_NATURAL_TREG_DN | 1.40e-06 | 181 | 115 | 8 | M2969 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 NRIP1 ERC1 SMCHD1 TSC22D2 ADAM10 CLIP1 KIF20B RIF1 BRCA1 CEP135 MACF1 PKN2 AGAP1 ZNF292 | 5.21e-06 | 856 | 115 | 15 | M4500 |
| Coexpression | ZHONG_PFC_C1_OPC | 1.05e-05 | 238 | 115 | 8 | M39096 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.50e-05 | 180 | 115 | 7 | M8239 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CTTNBP2 SMCHD1 ARMC10 PARP1 RIF1 BRCA1 N4BP2 ANP32E POLD3 VBP1 | 2.22e-05 | 434 | 115 | 10 | M15150 |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN | 2.87e-05 | 199 | 115 | 7 | M6199 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CTTNBP2 SMCHD1 ARMC10 PARP1 RIF1 BRCA1 N4BP2 ANP32E POLD3 VBP1 | 2.90e-05 | 448 | 115 | 10 | MM1044 |
| Coexpression | GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN | 2.96e-05 | 200 | 115 | 7 | M8069 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP | 2.96e-05 | 200 | 115 | 7 | M7905 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 2.96e-05 | 200 | 115 | 7 | M4449 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | TPM4 TICRR TRPV1 ATAD5 G2E3 ACVR2A SFR1 KIF20B NOD2 NPHP3 BRCA1 KIF15 N4BP2 MACF1 | 3.71e-05 | 892 | 115 | 14 | M18120 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NRIP1 SMCHD1 ADAM10 CLIP1 KIF20B BRCA1 CEP135 PKN2 AGAP1 ZNF292 | 4.04e-05 | 466 | 115 | 10 | M13522 |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 7.17e-05 | 230 | 115 | 7 | M11563 | |
| Coexpression | FAN_EMBRYONIC_CTX_NSC_2 | 7.78e-05 | 233 | 115 | 7 | M39036 | |
| Coexpression | FISCHER_DREAM_TARGETS | TICRR ATAD5 SMCHD1 G2E3 SFR1 KIF20B RIF1 BRCA1 KIF15 CEP135 ANP32E DCLRE1A POLD3 CEP57 | 9.01e-05 | 969 | 115 | 14 | M149 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | DOCK4 RIPOR2 CTTNBP2 IQGAP2 USP25 ARHGEF18 DGKH CLIP1 TRIP11 ARFGEF3 TOB1 AMOTL1 MACF1 | 9.74e-05 | 854 | 115 | 13 | M1533 |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 1.00e-04 | 168 | 115 | 6 | M18811 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | LAMB4 RIPOR2 SMCHD1 ARHGEF18 ADAM10 BBS9 KIF20B BLMH PARP1 RIF1 BRCA1 OSBPL3 DDX18 CEP135 ANP32E CEP57 YME1L1 | 1.23e-04 | 1394 | 115 | 17 | M9585 |
| Coexpression | GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_UP | 1.25e-04 | 175 | 115 | 6 | M396 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN | 1.25e-04 | 175 | 115 | 6 | M6694 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | SMCHD1 POLH G2E3 ACTN1 KIF20B RIF1 KIF15 N4BP2 CCAR1 ANP32E POLD3 CEP57 RBM17 | 1.27e-04 | 877 | 115 | 13 | M2241 |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP | 1.31e-04 | 340 | 115 | 8 | M2012 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | DOCK4 RIPOR2 CTTNBP2 IQGAP2 USP25 ARHGEF18 DGKH CLIP1 TRIP11 ARFGEF3 TOB1 AMOTL1 MACF1 | 1.43e-04 | 888 | 115 | 13 | MM1018 |
| Coexpression | LAIHO_COLORECTAL_CANCER_SERRATED_UP | 1.56e-04 | 115 | 115 | 5 | M16586 | |
| Coexpression | GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN | 1.70e-04 | 185 | 115 | 6 | M2965 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | 2.03e-04 | 272 | 115 | 7 | M15123 | |
| Coexpression | GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN | 2.19e-04 | 194 | 115 | 6 | M4687 | |
| Coexpression | GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP | 2.32e-04 | 196 | 115 | 6 | M5862 | |
| Coexpression | GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 2.32e-04 | 196 | 115 | 6 | M7551 | |
| Coexpression | GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN | 2.45e-04 | 198 | 115 | 6 | M3119 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | ATAD5 POLH SREBF1 G2E3 ACTN1 KIF20B RIF1 TOB1 BRCA1 KIF15 N4BP2 CEP135 POLD3 | 2.47e-04 | 939 | 115 | 13 | M45768 |
| Coexpression | GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN | 2.52e-04 | 199 | 115 | 6 | M5845 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 2.52e-04 | 199 | 115 | 6 | M5893 | |
| Coexpression | GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN | 2.52e-04 | 199 | 115 | 6 | M9749 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_NKCELL_DN | 2.52e-04 | 199 | 115 | 6 | M5531 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_DN | 2.58e-04 | 200 | 115 | 6 | M6354 | |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP | 2.58e-04 | 200 | 115 | 6 | M7039 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN | 2.58e-04 | 200 | 115 | 6 | M5167 | |
| Coexpression | GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN | 2.58e-04 | 200 | 115 | 6 | M9777 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN | 2.58e-04 | 200 | 115 | 6 | M7143 | |
| Coexpression | GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_DN | 2.58e-04 | 200 | 115 | 6 | M9240 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP | 2.58e-04 | 200 | 115 | 6 | M9205 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP | 2.58e-04 | 200 | 115 | 6 | M6090 | |
| Coexpression | GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP | 2.58e-04 | 200 | 115 | 6 | M7380 | |
| Coexpression | GSE34515_CD16_POS_MONOCYTE_VS_DC_UP | 2.58e-04 | 200 | 115 | 6 | M8765 | |
| Coexpression | GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_UP | 2.58e-04 | 200 | 115 | 6 | M6927 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | 2.64e-04 | 478 | 115 | 9 | M45785 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | DOCK4 RIPOR2 CTTNBP2 ERC1 ARFGEF3 TBC1D32 CDK5R1 LRRTM4 ANKRD12 SNX1 ZNF292 | 2.72e-04 | 703 | 115 | 11 | M39070 |
| Coexpression | GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_DN | 3.51e-04 | 137 | 115 | 5 | M8915 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 3.53e-04 | 212 | 115 | 6 | M39221 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 4.19e-04 | 404 | 115 | 8 | M19488 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | DOCK4 TICRR CDK12 TNIP3 LAMB1 KIF20B BLMH RIF1 GRPEL1 BRCA1 KIF15 DDX18 AMOTL1 CEP135 CCAR1 ANAPC5 | 4.30e-04 | 1407 | 115 | 16 | M14427 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | TPM4 ATAD5 CDK12 USP25 TSC22D2 KIF20B PPP1R7 RIF1 BRCA1 KIF15 N4BP2 CEP135 CEP57 RBM17 | 1.14e-06 | 532 | 115 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | ATAD5 CDK12 USP25 TNIP1 KIF20B RIF1 KIF15 CEP135 CCAR1 CEP57 YME1L1 ZNF292 RBM17 | 1.59e-06 | 469 | 115 | 13 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPM4 CERKL TICRR ATAD5 SMCHD1 G2E3 TLR7 CLIP1 KIF20B RIF1 BRCA1 KIF15 CEP135 CCAR1 ANP32E MACF1 CEP57 USP3 VBP1 DEUP1 DNMT3L ZNF292 RBM17 | 2.97e-06 | 1459 | 115 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPM4 TICRR ATAD5 SMCHD1 G2E3 TLR7 CLIP1 KIF20B RIF1 BRCA1 KIF15 CEP135 CCAR1 ANP32E MACF1 CEP57 USP3 VBP1 DNMT3L ZNF292 RBM17 | 3.52e-06 | 1257 | 115 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TICRR RIPOR2 IQGAP2 ATAD5 ERC1 G2E3 CLIP1 KIF20B RIF1 BRCA1 KIF15 LRRTM4 CEP135 CCAR1 ANP32E MACF1 USP3 DEUP1 ZNF292 | 4.02e-06 | 1060 | 115 | 19 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | TICRR KRT78 RIPOR2 IQGAP2 ATAD5 ERC1 G2E3 CLIP1 KIF20B RIF1 BRCA1 KIF15 SLIT1 LRRTM4 CEP135 CCAR1 ANP32E MACF1 USP3 DEUP1 DNMT3L ZNF292 | 6.25e-06 | 1414 | 115 | 22 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ATAD5 ADAM10 CLIP1 KIF20B RIF1 BRCA1 KIF15 CEP135 CCAR1 ZNF292 | 7.54e-06 | 311 | 115 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.00e-05 | 192 | 115 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | TPM4 TICRR ATAD5 SMCHD1 G2E3 KIF20B LRIG3 RIF1 BRCA1 KIF15 CEP135 CCAR1 ANP32E MACF1 CEP57 USP3 VBP1 ZNF292 RBM17 | 3.67e-05 | 1241 | 115 | 19 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ATAD5 ERC1 ARMC10 ACVR2A ADAM10 CLIP1 KIF20B RIF1 BRCA1 KIF15 CEP89 CEP135 CCAR1 ANAPC5 ZNF292 | 4.27e-05 | 831 | 115 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ATAD5 USP25 BBS9 KIF20B RIF1 BRCA1 KIF15 LRRTM2 CEP135 ANKRD12 POLD3 CEP57 HOMER2 | 5.46e-05 | 654 | 115 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | 1.02e-04 | 266 | 115 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | TPM4 CERKL TICRR ATAD5 SMCHD1 G2E3 KIF20B LRIG3 RIF1 BRCA1 KIF15 CEP135 CCAR1 ANP32E MACF1 CEP57 USP3 VBP1 ZNF292 RBM17 | 1.13e-04 | 1468 | 115 | 20 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | TICRR ATAD5 CLIP1 KIF20B RIF1 CCAR1 MACF1 ARHGEF2 GOLGB1 ZNF292 | 1.22e-04 | 432 | 115 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.04e-04 | 221 | 115 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 2.74e-04 | 232 | 115 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | ATAD5 USP25 KIF20B RIF1 BRCA1 KIF15 CEP135 HOMER2 DEUP1 DNMT3L | 3.52e-04 | 493 | 115 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.20e-04 | 328 | 115 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 4.88e-04 | 422 | 115 | 9 | GSM538355_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.23e-04 | 339 | 115 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-09 | 187 | 116 | 9 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 5.37e-08 | 199 | 116 | 8 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.37e-08 | 199 | 116 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 7.73e-08 | 138 | 116 | 7 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-07 | 157 | 116 | 7 | 0fecc14959c4c9efc19d5c06475a890e0a30f148 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.80e-07 | 194 | 116 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.35e-07 | 196 | 116 | 7 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 9.24e-07 | 199 | 116 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 9.24e-07 | 199 | 116 | 7 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.24e-07 | 199 | 116 | 7 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 9.56e-07 | 200 | 116 | 7 | 691b3edf7d8449556e8bf611662eb85772959f0f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 9.56e-07 | 200 | 116 | 7 | 36a110aa91a791fdf1142e7869e8aa0d342402d0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 9.56e-07 | 200 | 116 | 7 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 9.56e-07 | 200 | 116 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 9.56e-07 | 200 | 116 | 7 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.24e-06 | 168 | 116 | 6 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.99e-06 | 172 | 116 | 6 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.84e-06 | 176 | 116 | 6 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.77e-06 | 180 | 116 | 6 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.54e-06 | 183 | 116 | 6 | a716b446c2bf5aa294b8f580aa845098fae76354 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-06 | 185 | 116 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-06 | 187 | 116 | 6 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-06 | 187 | 116 | 6 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-06 | 187 | 116 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-06 | 187 | 116 | 6 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-05 | 189 | 116 | 6 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-05 | 190 | 116 | 6 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.06e-05 | 190 | 116 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 1.09e-05 | 191 | 116 | 6 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.09e-05 | 191 | 116 | 6 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l12-14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-05 | 192 | 116 | 6 | 52d0aa51e3b6ab3608a5f40bdde9f8134b3afd94 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.16e-05 | 193 | 116 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 193 | 116 | 6 | b835d28de9daeec5213172c96f62b332cda53bb5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.19e-05 | 194 | 116 | 6 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.19e-05 | 194 | 116 | 6 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-05 | 195 | 116 | 6 | 67670d16ddd5d5ab7bc2254df329f5a7b2581556 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.23e-05 | 195 | 116 | 6 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-05 | 195 | 116 | 6 | 23dc2f8a3a038195a31feee7e3a51094a7a7c23e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.23e-05 | 195 | 116 | 6 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.23e-05 | 195 | 116 | 6 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.23e-05 | 195 | 116 | 6 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | droplet-Tongue-TONGUE|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 196 | 116 | 6 | 44a30b1a5f3d8c845e5f3bd17d8102a7449f555b | |
| ToppCell | droplet-Tongue-TONGUE-1m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 196 | 116 | 6 | 9935bdb10789e8cfc922dca526ca3bf8317fe270 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 196 | 116 | 6 | a85f5f1e6acc798e9e02b1a21e0ffe87a323c333 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 196 | 116 | 6 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 196 | 116 | 6 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | normal_Lung-T/NK_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 1.34e-05 | 198 | 116 | 6 | c65cdb54409087014125a76627e5efb5fe8dabc9 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.38e-05 | 199 | 116 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 1.38e-05 | 199 | 116 | 6 | 2e9ee10a069afca5dbd9f0863cf90a66db1a6ffb | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.38e-05 | 199 | 116 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.38e-05 | 199 | 116 | 6 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.41e-05 | 200 | 116 | 6 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.41e-05 | 200 | 116 | 6 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.41e-05 | 200 | 116 | 6 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.41e-05 | 200 | 116 | 6 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.41e-05 | 200 | 116 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-05 | 200 | 116 | 6 | 38665128b54f4a81b53c961427aed67bf4e2510b | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.53e-05 | 156 | 116 | 5 | ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 5.53e-05 | 156 | 116 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-05 | 164 | 116 | 5 | 5621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.21e-05 | 165 | 116 | 5 | 26c750f10f6401752e2e63d91dc844c81b29d735 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.63e-05 | 167 | 116 | 5 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.63e-05 | 167 | 116 | 5 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-05 | 169 | 116 | 5 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.26e-05 | 174 | 116 | 5 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.77e-05 | 176 | 116 | 5 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.77e-05 | 176 | 116 | 5 | 90f8bb11f339f67f08692a0c33dd420f5cda2861 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.77e-05 | 176 | 116 | 5 | 8385435074cc5235b7af7424974f609388fc2cff | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-04 | 179 | 116 | 5 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 180 | 116 | 5 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.11e-04 | 181 | 116 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 182 | 116 | 5 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 182 | 116 | 5 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.17e-04 | 183 | 116 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-04 | 183 | 116 | 5 | 317b756378a9efd8ecb754acf7273f83f996e106 | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.20e-04 | 184 | 116 | 5 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 184 | 116 | 5 | 8260e688ec42a1374727bc85dceb7edd19a8b662 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-04 | 184 | 116 | 5 | 8f40093de5bb978f046d66e8f05f333686a009a4 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.23e-04 | 185 | 116 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 185 | 116 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.23e-04 | 185 | 116 | 5 | 9d424a8608b339dd6129c58d87626678d4ec4af7 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 1.23e-04 | 185 | 116 | 5 | 9d3168c7f0b1d739f78b368969cf5c77ce202b97 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 186 | 116 | 5 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.27e-04 | 186 | 116 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 186 | 116 | 5 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.33e-04 | 188 | 116 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-04 | 188 | 116 | 5 | e239bcdbd210a398a5850cb6fbf171d402f45a4f | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-04 | 188 | 116 | 5 | f5102e8d95506c25c675094b86162a6a50087b64 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 189 | 116 | 5 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 189 | 116 | 5 | 96f10c63656e446b4bb712f012e91ae986f8c2d0 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.40e-04 | 190 | 116 | 5 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-04 | 190 | 116 | 5 | cd37ccd30c27cf65eda0a9165f35b7672f5acaf6 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-04 | 191 | 116 | 5 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 191 | 116 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 191 | 116 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.43e-04 | 191 | 116 | 5 | 912e2d10d3423aa7f708fcf2b11da1845f12d7d3 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.43e-04 | 191 | 116 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-04 | 191 | 116 | 5 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.43e-04 | 191 | 116 | 5 | 77a2746b6d9c53b08d4405411c16fcc5a6c734ce | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 191 | 116 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.13e-07 | 50 | 69 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.65e-04 | 49 | 69 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.87e-04 | 50 | 69 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | Clorgyline | 2.40e-06 | 168 | 116 | 8 | ctd:D003010 | |
| Disease | Malignant neoplasm of breast | TPM4 NRIP1 POLH TNIP1 ADAM10 CLIP1 PARP1 RIF1 BRCA1 ZNF277 N4BP2 DDX18 ZNF432 MACF1 ANAPC5 GOLGB1 | 2.70e-06 | 1074 | 111 | 16 | C0006142 |
| Disease | Alzheimer disease, diastolic blood pressure | 4.20e-05 | 3 | 111 | 2 | EFO_0006336, MONDO_0004975 | |
| Disease | Growth abnormality | 4.20e-05 | 3 | 111 | 2 | C0262361 | |
| Disease | response to silica exposure, pneumoconiosis | 1.39e-04 | 5 | 111 | 2 | EFO_0005853, MONDO_0015926 | |
| Disease | Macrothrombocytopenia | 1.39e-04 | 5 | 111 | 2 | C2751260 | |
| Disease | eosinophil count | CPA4 NRIP1 SREBF1 ARHGEF18 TNIP1 DGKH ACVR2A GRPEL1 BRCA1 PKN2 USP3 TET3 LRRC36 DNMT3L RAPGEFL1 ZNF292 | 1.42e-04 | 1488 | 111 | 16 | EFO_0004842 |
| Disease | cortical surface area measurement | CPA4 TICRR CTTNBP2 IQGAP2 SREBF1 TSC22D2 ACVR2A BBS9 KIF20B GATAD2B CCAR1 MACF1 PKN2 POLD3 AGAP1 | 1.57e-04 | 1345 | 111 | 15 | EFO_0010736 |
| Disease | Lissencephaly | 2.08e-04 | 6 | 111 | 2 | C0266463 | |
| Disease | mean corpuscular hemoglobin concentration | TICRR IQGAP2 CDK12 RIF1 NPHP3 MACF1 PKN2 ANKRD12 FKBP8 CEP57 GOLGB1 AGAP1 XPO7 | 2.67e-04 | 1105 | 111 | 13 | EFO_0004528 |
| Disease | cortical thickness | CPA4 RIPOR2 CTTNBP2 SREBF1 TSC22D2 ADAM10 BBS9 KIF20B GATAD2B CCAR1 MACF1 HOMER2 AGAP1 | 2.86e-04 | 1113 | 111 | 13 | EFO_0004840 |
| Disease | Autosomal dominant macrothrombocytopenia | 2.91e-04 | 7 | 111 | 2 | C4304021 | |
| Disease | autoimmune disease (is_implicated_in) | 3.87e-04 | 8 | 111 | 2 | DOID:417 (is_implicated_in) | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 4.28e-04 | 93 | 111 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | Abnormality of the face | 4.96e-04 | 9 | 111 | 2 | C4025871 | |
| Disease | indoleacetate measurement | 6.19e-04 | 10 | 111 | 2 | EFO_0021015 | |
| Disease | Bardet-Biedl syndrome (implicated_via_orthology) | 7.54e-04 | 11 | 111 | 2 | DOID:1935 (implicated_via_orthology) | |
| Disease | methionine sulfone measurement | 9.03e-04 | 12 | 111 | 2 | EFO_0800072 | |
| Disease | disease recurrence, colon carcinoma | 9.46e-04 | 51 | 111 | 3 | EFO_0004952, EFO_1001950 | |
| Disease | Dermatitis | 1.63e-03 | 16 | 111 | 2 | C0011603 | |
| Disease | respiratory symptom change measurement, response to placebo | 1.84e-03 | 17 | 111 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 1.84e-03 | 17 | 111 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | Systemic Scleroderma | 2.30e-03 | 19 | 111 | 2 | C0036421 | |
| Disease | event free survival time, urinary bladder cancer | 2.30e-03 | 19 | 111 | 2 | EFO_0000482, MONDO_0001187 | |
| Disease | leprosy, Crohn's disease | 2.55e-03 | 20 | 111 | 2 | EFO_0000384, EFO_0001054 | |
| Disease | body weight | IPPK CWH43 ATAD5 SMCHD1 DGKH TSC22D2 CLIP1 SLIT1 POLD3 AGAP1 RAPGEFL1 XPO7 | 2.83e-03 | 1261 | 111 | 12 | EFO_0004338 |
| Disease | Sensorineural Hearing Loss (disorder) | 3.37e-03 | 23 | 111 | 2 | C0018784 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TKLNLQKSNRNSLLA | 776 | Q9BXU7 | |
| NDDLLKVSSLCNNNK | 546 | Q96QE3 | |
| SSASFDLKQQLLLNK | 1261 | Q6ZSZ5 | |
| KCSNILLNNSGQIKL | 861 | Q9NYV4 | |
| KCQLEINFNTLQTKL | 331 | P12814 | |
| LSNCRKLKKLNLNAS | 81 | Q8IY45 | |
| QILASLQSCESSKNK | 586 | Q9UPQ3 | |
| LNNENLKKSLSCANL | 81 | Q15078 | |
| EELSLLAQNKQSSKL | 341 | Q9UJW3 | |
| KQQQTSIKSSLLCLQ | 1046 | Q96NH3 | |
| EKTILNLENSNKSLS | 1066 | Q8IX12 | |
| KLNNNKFSLCSIRNI | 426 | O14672 | |
| AALLKNNTALQSVSL | 96 | Q92974 | |
| KNVLLKNNLTACIAD | 326 | P27037 | |
| QTSNNCKNSLTELLL | 986 | A2A2Z9 | |
| SQLLAAENKCNLLEK | 131 | Q86XR8 | |
| STKILQKNNLNLLRD | 281 | Q9BTE6 | |
| KLQQALTQLQSACEK | 611 | Q8IY63 | |
| NLKNLKSLDLFNCEI | 111 | Q9BTT0 | |
| SLLQAKEKTQQSLAA | 1801 | Q6UB98 | |
| SLDAQQKLLSEKCNQ | 166 | Q05D60 | |
| NQSIKEKALNALNNL | 151 | Q8N2F6 | |
| AQLNKLTQLATKCLE | 51 | P61578 | |
| LNDSSQQLQDSLRKK | 821 | Q8IUD2 | |
| ALKSLLQEAQNNLKI | 196 | Q9H8X2 | |
| CSTNDLKELLIFNKQ | 256 | P09874 | |
| FTLLKSLSLNNNKLT | 61 | Q8N9N7 | |
| ICNLKKLETLSLNNN | 81 | Q8N9N7 | |
| VANLSSLLSELNKKQ | 56 | O43827 | |
| LSQQASLLKNDETKA | 216 | Q9UJX4 | |
| NNKLNSLDSKILNSL | 286 | O43300 | |
| CLFANTEKLKAQLLQ | 576 | Q9NS87 | |
| KLNLDSNKLTNISQE | 281 | Q86VH4 | |
| KNLCLNKSSLDFSAN | 1011 | Q6UXM1 | |
| LLCTATKQKNSGQNL | 26 | Q9HAV7 | |
| LASLKTLDLSNNQLS | 201 | Q8N1G4 | |
| NDKLKIALTQSAANV | 166 | Q9NSB8 | |
| KLNDQANTLTDLAKT | 446 | Q92952 | |
| SGKTNLCQLSLSKLN | 1986 | Q5CZC0 | |
| QALLEKNLSTATKNL | 141 | P61758 | |
| ASNKVSLALLQKQLS | 376 | Q9HB15 | |
| LQKKLSLLIDSFQNN | 16 | Q96B96 | |
| QVACLNQELAQLKKL | 656 | Q1X8D7 | |
| LLSNLQELDLSANKK | 336 | Q6UY01 | |
| QQELSLSEKKNLTLS | 916 | Q96Q89 | |
| LKKQNASLQAAITDA | 346 | Q8N1N4 | |
| SQKNCHQTLLKTLNA | 16 | Q8IV20 | |
| KSFNVLKQLLLSENC | 931 | P48552 | |
| AKTLLAQANSKLQLL | 1726 | P07942 | |
| ANSQAAAKLALRKQL | 346 | Q8WXI9 | |
| SLCNLVNENTLKAIK | 181 | Q9NVP1 | |
| KCSVLNEKLEQLLQA | 546 | Q86XP1 | |
| LKNLSLKLDDLSTCN | 306 | Q969R2 | |
| KSSKEQALNLNSQLN | 786 | Q3SYG4 | |
| LNCEEKLTLAKNTLQ | 441 | Q9UPN3 | |
| SQACSNKNLEKLRAQ | 5046 | Q9UPN3 | |
| KNDNLLKALQLNELT | 686 | Q6S8J3 | |
| CLSKNTEENLLSLKN | 1251 | P38398 | |
| LSLKNSLNDCSNQVI | 1261 | P38398 | |
| VNLSNKNEKLCQELT | 306 | Q66GS9 | |
| SKNLSLNSQALKENL | 431 | Q7L622 | |
| QLLQLKVKCLNNLAA | 266 | Q14318 | |
| LENKNQQLKTLISQC | 1476 | Q8N1I0 | |
| QLNCNRNASLSKQKS | 1491 | Q8WZ74 | |
| SKQKSLENDLSLTLN | 1501 | Q8WZ74 | |
| SLLLEKNSLTEQNKA | 551 | Q96ST8 | |
| AALSLKLLKNQEADQ | 656 | Q5TH69 | |
| EISKLSQLVNSNNLK | 36 | Q9UI42 | |
| NKLKNSTLDLINLSE | 131 | Q49MI3 | |
| LNSEKVAALIQKLNS | 6 | Q13867 | |
| KAANILLNLDKTLNQ | 1561 | A4D0S4 | |
| IRKLSSENLNAKNNT | 486 | Q6PJP8 | |
| NSVAITAKLLQQKLN | 846 | Q9UQL6 | |
| LVNNKISKIENLSNL | 171 | Q15435 | |
| NDSQKAVKILQSLSA | 416 | O95396 | |
| LQLKLTKANENASFL | 961 | P30622 | |
| LKQAAAQKSQQLSAL | 1161 | P30622 | |
| KNALSSALAQNTDLK | 381 | Q9H4L5 | |
| NLDLLLQTKNSSKVL | 371 | Q9H720 | |
| DNLNKLKNLCSKTIG | 51 | P49591 | |
| DCLILLQNLLKNNNS | 231 | O60763 | |
| VCKLDSVNKDLNSQL | 1916 | A6NHR9 | |
| SLLGQLQNITKKENC | 311 | Q5H9J9 | |
| ALLKSLSSNDQLSQL | 731 | O75157 | |
| ALIAVNLKNSLKQLT | 436 | Q7LBE3 | |
| QSLNNLAALCNEKKQ | 1136 | Q7Z494 | |
| NALELLSKLNDTIKN | 96 | Q5UIP0 | |
| AELAKLQQTLNALNK | 1416 | Q13576 | |
| LLSKLANTNNNKLRH | 926 | Q5T2S8 | |
| FLNNSTSLLKCQSDK | 746 | Q8NDZ2 | |
| KNDNLLKALQLNELT | 686 | P0CG38 | |
| SLLLKQKQLNNSSVS | 536 | Q9Y253 | |
| QLAQLPSSKNSLLKD | 246 | Q5VTB9 | |
| ILKSNLQNCSKFSAI | 121 | Q15054 | |
| CSTSNNRLKALQKQL | 131 | Q16513 | |
| ENTNLKNTLKNLNVC | 111 | Q86XK3 | |
| KNTLKNLNVCESQSL | 116 | Q86XK3 | |
| LTKTNLQLQKAACLA | 986 | Q9Y4F9 | |
| SNQKLKQENLSLRTA | 376 | P36956 | |
| KLQAQVTLSNAQLKA | 496 | Q15025 | |
| NCLNQVKSSLLKTSK | 686 | Q7Z2Z1 | |
| LKNVTNNLKSLEAAS | 161 | P67936 | |
| RLNKALQDALNIKCS | 161 | Q96KP6 | |
| KNSSLKILKLSNNCI | 981 | Q9HC29 | |
| LSLDSTQNNQKKVLA | 96 | Q13596 | |
| NCQDLESLLLFLQKS | 126 | Q8NER1 | |
| LQSQLQVKKAALTQA | 26 | Q96I25 | |
| KTNQLSQATALAKLC | 201 | O60281 | |
| QLAQKALQEKLLASQ | 706 | Q9UHP3 | |
| QSALSIAKEKNISLQ | 341 | O43151 | |
| CSRSLKNLILKNNQI | 721 | Q9NYK1 | |
| LNVNDLLKQKAISSS | 211 | P50616 | |
| FLKAQALTQKTNDSL | 276 | Q96TA2 | |
| LLENSTLNSKLLKVN | 136 | Q9Y6I4 | |
| NEFLCTLQKKLDNLQ | 211 | Q9NRM2 | |
| LNQDSNSNFKDTLLK | 631 | Q15643 | |
| TLKSNLSLVNQNKSC | 136 | O94892 | |
| TLSCNLLKQASGKNL | 191 | Q9UIA9 | |
| KLNENTLKLNQTIAS | 231 | Q9C037 | |
| KIAALCKQNQDLLSF | 501 | Q9UHV5 | |
| ATDLKNLQLDKNQIS | 156 | O75093 | |
| LQSACDALKDQNSKL | 391 | Q14789 | |
| IAGCSSLNQKQKELL | 256 | Q86UW6 |